Mostrar el registro sencillo del ítem

Artículo

dc.creatorLópez Bueno, Rubénes
dc.creatorCalatayud, Joaquínes
dc.creatorPozo Cruz, Jesús deles
dc.creatorYang, Lines
dc.creatorPozo Cruz, Borja deles
dc.date.accessioned2024-07-10T10:37:56Z
dc.date.available2024-07-10T10:37:56Z
dc.date.issued2024
dc.identifier.citationLópez Bueno, R., Calatayud, J., Pozo Cruz, J.d., Yang, . y Pozo Cruz, B.d. (2024). Dose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United States. Progress in Cardiovascular Diseases, 1-31. https://doi.org/10.1016/j.pcad.2024.06.001.
dc.identifier.issn0033-0620es
dc.identifier.issn1873-1740es
dc.identifier.urihttps://hdl.handle.net/11441/161257
dc.description.abstractBackground Our aim was to examine the prospective dose-response associations of American Heart Association´s (AHA) LIFE´s Essential 8 (LE8) score and number of cardiovascular health (CVH) factors with high score with all-cause and cardiovascular disease (CVD) related mortality. Methods We pooled 6 consecutive waves of the National Health and Nutrition Examination Survey (NHANES) comprising rounds between 2007-2008 and 2017-2018. We calculated hazard ratios (HRs) and conducted restricted cubic splines models to assess the dose-response association of LE8 score and CVH factors with all-cause and CVD mortality. Results Analyses included 23 531 adults aged 18 years and over (mean [SD] age, 43.6 [16.7] years; 11 979 [51%] female; 8960 [38.1%] non-Hispanic white individuals) with a median follow-up of 7.3 years (IQR 4.3-10.1), corresponding to 168 033 person-years. The dose-response analyses showed a significant inverse curvilinear trend for the association between LE8 score with all-cause and CVD mortality. The optimal risk reduction for all cause mortality was found at 100 points of the LE8 Score (HR, 0.50; 95% CI, 0.27-0.93) compared to the reference (median LE8 score [62.5 points]). Moreover, the dose-response association between LE8 and CVD mortality also exhibited a significant inverse curvilinear association up to 90 points (HR, 0.41; 95% CI, 0.17-0.99). Optimal levels of LE8 score may Journal Pre-proof 2 Journal Pre-proof be able to avert around 40% of the annual all-cause and CVD deaths among the US adult population. Conclusions Best-case scenario of CVH may reduce around 40% of the all-cause and CVD annual mortality among adults in the United States.es
dc.formatapplication/pdfes
dc.format.extent31 p.es
dc.language.isoenges
dc.publisherElsevieres
dc.relation.ispartofProgress in Cardiovascular Diseases, 1-31.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectPreventive medicinees
dc.subjectEpidemiologyes
dc.subjectPublic healthes
dc.subjectRisk factorses
dc.subjectLifestylees
dc.titleDose-response associations of the American Heart Association's new “Life's essential 8” metrics with all-cause and cardiovascular mortality in a nationally representative sample from the United Stateses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Educación Física y Deportees
dc.relation.publisherversionhttps://doi.org/10.1016/j.pcad.2024.06.001es
dc.identifier.doi10.1016/j.pcad.2024.06.001es
dc.contributor.groupUniversidad de Sevilla. HUM1055: Epidemiology of Physical Activity and Fitness Across Lifespanes
idus.validador.notaPaquies
dc.journaltitleProgress in Cardiovascular Diseaseses
dc.publication.initialPage1es
dc.publication.endPage31es

FicherosTamañoFormatoVerDescripción
Dose response associations of ...1.230MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional